Dentists in Overland Park, KS Accepting Medicare
167 Dentists found. Showing 161 - 167
 Anuja Buch, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 9906 College Blvd, Overland Park, KS 66210 Phone: 913-345-1181 Fax: 913-345-1823 |
Dr. Kelly Nicole Tabacchi, DDS Dentist - Orthodontics and Dentofacial Orthopedics Medicare: Not Enrolled in Medicare Practice Location: 7001 W 121st St, Overland Park, KS 66209 Phone: 913-953-6767 |
 Dr. Dale Douglas Watts Ii Ii, DDS Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 4601 W 109th St Ste 222, Overland Park, KS 66211 Phone: 913-338-3384 Fax: 913-338-3389 |
Dr. Mark Andrew Holman, D.D.S. Dentist - Endodontics Medicare: Medicare Enrolled Practice Location: 4601 W 109th St, Suite 250, Overland Park, KS 66211 Phone: 913-438-3636 Fax: 913-498-0935 |
Dr. Richard Harold Willits, DDS Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 12870 Metcalf Ave, Overland Park, KS 66213 Phone: 913-851-8400 |
Dr. Ross S Headley, DDS Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 12850 Metcalf Ave, Ste 200, Overland Park, KS 66213 Phone: 913-491-6874 Fax: 913-491-6917 |
Dr. Chaz Michael Gibbons, DMD Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 8700 Santa Fe Dr, Overland Park, KS 66212 Phone: 913-416-6602 |
News Archive
Scientists develop robotic systems for image-guided removal of hard-to-reach brain tumors
NIBIB-funded scientists and engineers are teaming up with neurosurgeons to develop technologies that enable less invasive, image-guided removal of hard-to-reach brain tumors.
ChemoCentryx reports one-year study results of Traficet-EN in Crohn's disease patients
ChemoCentryx, Inc., today announced that it reported one-year results from the Company's PROTECT-1 Study (the Prospective Randomized Oral Therapy Evaluation in Crohn's disease Trial) of Traficet-EN™ (CCX282-B) in patients with moderate-to-severe Crohn's disease. Traficet-EN, an orally bioavailable CCR9-specific chemokine receptor antagonist showed clinical efficacy in a 12-week Induction period, as well as a 36-week Maintenance period.
Patients challenge hospital fees
The Boston Globe reports on this trend. In other news, CQ HealthBeat reports that the Medicare Payment Advisory Commission gave a nod to shared-decision making between doctors and patients.
Imaging algorithm distributed in top-down fashion reduces unnecessary cervical spine radiographs
An imaging algorithm produced by a radiology department and distributed through the medical director's office, in a top-down fashion, enabled a large, academic medical center to significantly reduce the number of unnecessary cervical spine radiographs (X-rays) in the emergency department, according to a study published in the July issue of the Journal of the American College of Radiology.
› Verified 8 days ago
Counselors
Pharmacists
Occupational Therapists
Dentists
Clinical Social Workers
Psychologists